Mester, P.; Keller, D.; Kunst, C.; Räth, U.; Rusch, S.; Schmid, S.; Krautbauer, S.; Müller, M.; Buechler, C.; Pavel, V.
High Serum S100A12 as a Diagnostic and Prognostic Biomarker for Severity, Multidrug-Resistant Bacteria Superinfection and Herpes Simplex Virus Reactivation in COVID-19. Viruses 2024, 16, 1084.
https://doi.org/10.3390/v16071084
AMA Style
Mester P, Keller D, Kunst C, Räth U, Rusch S, Schmid S, Krautbauer S, Müller M, Buechler C, Pavel V.
High Serum S100A12 as a Diagnostic and Prognostic Biomarker for Severity, Multidrug-Resistant Bacteria Superinfection and Herpes Simplex Virus Reactivation in COVID-19. Viruses. 2024; 16(7):1084.
https://doi.org/10.3390/v16071084
Chicago/Turabian Style
Mester, Patricia, Dennis Keller, Claudia Kunst, Ulrich Räth, Sophia Rusch, Stephan Schmid, Sabrina Krautbauer, Martina Müller, Christa Buechler, and Vlad Pavel.
2024. "High Serum S100A12 as a Diagnostic and Prognostic Biomarker for Severity, Multidrug-Resistant Bacteria Superinfection and Herpes Simplex Virus Reactivation in COVID-19" Viruses 16, no. 7: 1084.
https://doi.org/10.3390/v16071084
APA Style
Mester, P., Keller, D., Kunst, C., Räth, U., Rusch, S., Schmid, S., Krautbauer, S., Müller, M., Buechler, C., & Pavel, V.
(2024). High Serum S100A12 as a Diagnostic and Prognostic Biomarker for Severity, Multidrug-Resistant Bacteria Superinfection and Herpes Simplex Virus Reactivation in COVID-19. Viruses, 16(7), 1084.
https://doi.org/10.3390/v16071084